BIO-Europe 2023 - Germany | Informa Connect | 23 October 2022 | Leipzig Messe, Leipzig, Germany

All under one roof. Over the course of three days. Meet, engage and network with over 4,000 global biopharma executives and take part in the 25,000+ one-to-one meetings that will take place at the event.

2022 Speakers

Khatereh Ahmadi
Head of Search and Evaluation Business Development, Europe and Middle East, MSD

Hiroyuki Akatsuka
Associate Directorm, Life Sciences Industry Division, Osaka Prefectural Government

Christopher Aleong
Managing Director, North America & Head of Global Licensing, BioEngine Technology Development Inc.

Isabel Antholz
Managing Director, Mannin GmbH

Daniela Begolo
Principal, Inkef

Sascha Berger
Partner, TVM Capital

Fabian Berkemeier
Director, Value & Access Strategy, IGES Institut

Hubert Birner
Managing Partner, TVM Capital

Ulrica Slåne Bjerke
Founder and CIO, Arctic Aurora Life Science

Ezio Bonifacio
Professor, CRTD, TU Dresden

Julia Busch-Casler
Head of the Digital Health, Fraunhofer IMW

Rebecca Canter
Senior Director, Venture Sciences Europe, Eli Lilly and Company

Josep-Maria Casanovas
Head of Immuno-Dermatology External Innovation and Licensing, Corporate Development, Almirall

Daniel Chancellor
Thought Leadership and Consulting Direct, Citeline

Ruth Ciesinger
Online Managing Editor, der Tagesspiegel

Ashley Cox
Senior Principal, Head of Europe, EVERSANA Management Consultancy

Chad Davis
Partner, Dechert LLP

Erin Denny
Head of Oncology Search & Evaluation, Business Development, Amgen

Florian Diwischek
Head HE&OR, Novartis

John Easton
Board Advisor, Sterling Technology

Duncan Emerton
Executive Director, Consulting, Citeline

Kerem Erden
VP and Head of Collaborate2Cure Hub EMEA, Bayer AG

Elena Fernandez- Kleinlein
Head of JLabs EMEA, Johnson & Johnson Innovation

Susanne Fiedler
Chief Commercial Officer, Organon

Anke Fuchs
Research Group Leader, Center for Regenerative Therapies Dresden (CRTD)

Norman Gerstner
CEO, Biotype GmbH

Yuri (Jurijus) Gleba
CEO, Nomad Bioscience GmbH

Mireia Gomez Angelats
Chief Business Officer, Topas Therapeutics

Uli Grabenwarter
Deputy Director, Equity Investments & Guarantees, EIF

Anton Gueth
Managing Director, EVOLUTION Life Science Partners

John Haurum
Chairman, JSH Biotech Aps.

Andre Hofmann
CEO, biosaxony e.V.

Peter Homberg
Lawyer, Dentons LLP

Dmitrij Hristodorov
Partner, Forbion

Nouhad Husseini
Vice President, Business Development, Regeneron Pharmaceuticals, Inc.

Friedemann Janus
Senior VP, Head of Business Development & Licensing, Open Innovation and Divestitures, Bayer AG, Berlin, Germany

Christian Jung
Partner, SV Health Investors

Tahera Kan
VP, Early Innovation Partnering, Johnson & Johnson Innovation

Nicola Kidman
Principal Consultant - Regulatory Affairs, Arriello

Karin Kleinhans
Partner, MRLV

Victor Klimyuk
Managing Director/COO, Icon Genetics GmbH

Olaf Koenig
Executive Director, Amgen

Matthias Kromayer
Managing Partner, MIG Capital AG

Ulrike Köhl
Director, Fraunhofer Institut für Zelltherapie und Immunologie (IZI)

Jenny Laird
VP, Search & Evaluation Neuroscience, Eli Lilly and Company

Tomas Landh
Innovation Sourcing VP, Senior Principal Scientist R&D Global S&E, Global R&D BD, Novo Nordisk

Laura Lane
Vice President Venture Science (Head of Europe),Eli Lilly and Company

Werner Lanthaler
CEO, Evotec

Peng Leong
Chief Business Officer & Head of Brain Aging, BioAge Labs

Stephanie Leouzon
Partner and Head of Torreya Europe, Torreya

Olivier Litzka
Partner, Andera Partners Life Sciences

Peter Llewellyn-Davies
President, Biotech Austria

Philippe Lopes-Fernandes
Executive Vice President and Chief Business Officer, IPSEN

Roman Mathaes
Head of Pharmaceutical Services, Lonza

Detlev Mennerich
SVP, heading Global BD&L, Boehringer Ingelheim

Marianne Mertens
Partner, Apollo Health Ventures

Laura Millichamp
Founder, InsideReg

Shardha Millington
Consultant, Citeline

Faical Miyara
Head of Global Partnering, Oncology, Ipsen

Bernd Muehlenweg
Senior VP, Global Business Development, Evotec

Matthias Muellenbeck
SVP, Head Global Business Development & Alliance Management, Merck KGaA, Darmstadt, Germany

Marlis Müllner
Director R&D Investment, Austrian Business Agency

Barbara Natke
VP, Business Development, AVEO Oncology

Panu Noppari
Formulation Scientist, Nanoform

Hugh Nuthall
Senior Director, Search & Evaluate, Eli Lilly and Company

Kieran O'Donnell
VP Global Drug Safety, Arriello

Stephanie Oestreich
Chief Business Officer, Galecto Biotech

Linda Pullan
Founder, ullan Consulting

Holger Reithinger
Partner, Forbion

Toby Richardson
Senior Director, Early Innovation Partnering, Immunology, Johnson & Johnson Innovation EMEA

Anna Rivkin
VP, Business Development for Cardiovascular, Fibrosis, Immunology & Neuroscience, BMS

Christian Rommel
Head of PH Research & Development, Bayer AG

Vis
Director, Corporate Business Development & Strategy, H. Lundbeck A/S

Zaki Salanti
Senior Director, Head of Search & Evaluation, Novo Nordisk A/S

Isabelle Scarabin
Director, Business Development & Licensing Officer, Bayer

Stephan Schilling
Head of the Department of Drug Design and Target Validation, Fraunhofer IZI

Eva Schlintl
Investment Manager, LISA – Life Science Austria on behalf of Austria Wirtschaftsservice GmbH

David Schmitt
Head of Product Development - BioProduct Delivery division - Europe, Catalent Biologics, Catalent Pharma Solutions

Stefan Schneider
EMA Head of Life Sciences, KPMG AG Wirtschaftsprüfungsgesellschaft

Sebastian Schuck
Global Director Business Development, Wacker Biotech GmbH

Evonne Sepsis
Founder and Managing Director, ESC Advisors

Florian Settele
Head of Business Unit Precision Capturing, Navigo Proteins GmbH

Sander Slootweg
Managing Partner, Forbion

Charlotte Smerdon
Cell & Gene Centre of Excellence Lead, Portfolio Director Project Management, Veristat

Catello Somma
Associate, TVM Capital

Kerstin Stangier
Senior Director Global Integration, Azenta / GENEWIZ

Katja Stout
Managing Director, Scius Communications

Michael Taeger
CEO, BMD Life Sciences GmbH

Hidetoshi Tahara
Vice President, Hiroshima University

Dorit Teichmann
Project Manager SaxoCell, Technische Universität Dresden

Michael Thompson
CEO, DyNAbind GmbH

Thomas Tradler
Head of Business Development and Patent Management, Fraunhofer IZI

Sandy Tretbar
Group Leader, Fraunhofer Institute for Cell Therapy and Immunology (IZI)

Yoshiaki Tsukamoto
Executive Director, Japan Bioindustry Association (JBA)

Felice Verduyn-van Weegen
Partner, EQT group

Ulrike Weirauch
Senior Scientist, Biomarker Center at the Fraunhofer Institute for Cell Therapy and Immunology

Roberto Zanchi
Head of Business Development and Commercialisation, Quadram Institute Bioscience

Keely Zipp
Founder, Stark Strategic Advisors

2022 Sponsors

REGIONAL HOST:
• biosaxony

PLATINUM SPONSORS:
• AMGEN
• Bayer
• BioConnection
• BioWin
• Boehringer Ingelheim International
• Caregen
• IPSEN
• Lilly
• LISA - Life Science Austria
• LISAvienna
• MERCK
• MSD
• Rentschler Biopharma SE
• Roche
• Walloonia.be

GOLD SPONSORS:
• Almirall
• Arriello
• Dechert
• Lonza
• nanoform
• Novartis
• Novo Nordisk
• Servier
• Pfizer
• Richter Helm
• SGS
• Single Use Support
• STERLING
• VERISTAT
• Vetter
• WuXi Apptec

SILVER SPONSORS:
• Andera Partners
• BioAge Labs
• EVOLUTION Life Science Partners
• Evotec
• FUJIFILM Diosynth
• GenScript Probio
• MINARIS
• Sanofi